Advertisement
Screener

SOLIGENIX, INC. (SNGX) Earnings Per Share (Basic)

2.8 / 5 stars · 68/120 Roast Me

SOLIGENIX, INC. Earnings Per Share (Basic)

SOLIGENIX, INC. (SNGX) reported Earnings Per Share (Basic) of -$0.12 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasic · last filed 2026-08-07

  • SOLIGENIX, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.12.
  • SOLIGENIX, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.28.
  • SOLIGENIX, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.29.
  • SOLIGENIX, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.58.
  • SOLIGENIX, INC. earnings per share, basic for fiscal 2025 was -$2.14.
  • SOLIGENIX, INC. earnings per share, basic for fiscal 2024 was -$4.98.
  • SOLIGENIX, INC. earnings per share, basic for fiscal 2023 was -$12.66.
  • SOLIGENIX, INC. earnings per share, basic for fiscal 2022 was -$4.81.
Period endEarnings Per Share, Basic 3 monthEarnings Per Share, Basic 3 month as first filedEarnings Per Share, Basic 6 monthEarnings Per Share, Basic 6 month as first filedEarnings Per Share, Basic 9 monthEarnings Per Share, Basic 9 month as first filedEarnings Per Share, Basic 12 monthEarnings Per Share, Basic 12 month as first filed
2026-06-30-$0.12
10-Q · filed 2026-08-07
-$0.37
10-Q · filed 2026-08-07
-$0.64
derived: net income ÷ weighted average shares · filed 2026-08-07
-$1.01
derived: net income ÷ weighted average shares · filed 2026-08-07
2026-03-31-$0.28
10-Q · filed 2026-05-08
-$0.57
derived: net income ÷ weighted average shares · filed 2026-05-08
-$1.01
derived: net income ÷ weighted average shares · filed 2026-05-08
-$1.57
derived: net income ÷ weighted average shares · filed 2026-08-07
2025-12-31-$0.29
derived: net income ÷ weighted average shares · filed 2026-03-31
-$0.75
derived: net income ÷ weighted average shares · filed 2026-03-31
-$1.38
derived: net income ÷ weighted average shares · filed 2026-08-07
-$2.14
10-K · filed 2026-03-31
2025-09-30-$0.58
10-Q · filed 2025-11-07
-$1.38
derived: net income ÷ weighted average shares · filed 2026-08-07
-$2.30
10-Q · filed 2025-11-07
-$3.39
derived: net income ÷ weighted average shares · filed 2026-08-07
2025-06-30-$0.82
10-Q · filed 2026-08-07
-$1.79
10-Q · filed 2026-08-07
-$2.93
derived: net income ÷ weighted average shares · filed 2026-08-07
-$3.75
derived: net income ÷ weighted average shares · filed 2026-08-07
2025-03-31-$0.97
10-Q · filed 2026-05-08
-$1.06
10-Q · filed 2025-05-09
-$2.14
derived: net income ÷ weighted average shares · filed 2026-05-08
-$2.96
derived: net income ÷ weighted average shares · filed 2026-05-08
-$4.12
derived: net income ÷ weighted average shares · filed 2026-05-08
2024-12-31-$1.19
derived: net income ÷ weighted average shares · filed 2026-03-31
-$2.00
derived: net income ÷ weighted average shares · filed 2026-03-31
-$3.19
derived: net income ÷ weighted average shares · filed 2026-03-31
-$4.98
10-K · filed 2026-03-31
2024-09-30-$0.78
10-Q · filed 2025-11-07
-$1.94
derived: net income ÷ weighted average shares · filed 2025-11-07
-$3.84
10-Q · filed 2025-11-07
-$5.95
derived: net income ÷ weighted average shares · filed 2025-11-07
2024-06-30-$1.31
10-Q · filed 2025-08-14
-$3.71
10-Q · filed 2025-08-14
-$6.29
derived: net income ÷ weighted average shares · filed 2025-08-14
-$8.76
derived: net income ÷ weighted average shares · filed 2025-08-14
2024-03-31-$2.91
10-Q · filed 2025-05-09
-$0.18
10-Q · filed 2024-05-10
-$5.71
derived: net income ÷ weighted average shares · filed 2025-05-09
-$8.27
derived: net income ÷ weighted average shares · filed 2025-05-09
-$11.63
derived: net income ÷ weighted average shares · filed 2025-05-09
2023-12-31-$2.80
derived: net income ÷ weighted average shares · filed 2025-03-21
-$5.36
derived: net income ÷ weighted average shares · filed 2025-03-21
-$8.72
derived: net income ÷ weighted average shares · filed 2025-03-21
-$12.66
10-K · filed 2025-03-21
-$0.79
10-K · filed 2024-03-15
2023-09-30-$2.56
10-Q · filed 2024-11-08
-$0.16
10-Q · filed 2023-11-13
-$5.94
derived: net income ÷ weighted average shares · filed 2024-11-08
-$10.05
10-Q · filed 2024-11-08
-$0.63
10-Q · filed 2023-11-13
-$4.68
derived: net income ÷ weighted average shares · filed 2024-11-08
2023-06-30-$3.56
10-Q · filed 2024-08-09
-$0.22
10-Q · filed 2023-08-21
-$8.35
10-Q · filed 2024-08-09
-$0.52
10-Q · filed 2023-08-21
-$3.08
derived: net income ÷ weighted average shares · filed 2024-08-09
-$4.26
derived: net income ÷ weighted average shares · filed 2024-08-09
2023-03-31-$0.36
10-Q · filed 2024-05-10
-$1.66
derived: net income ÷ weighted average shares · filed 2024-05-10
-$2.81
derived: net income ÷ weighted average shares · filed 2024-05-10
-$3.64
derived: net income ÷ weighted average shares · filed 2024-05-10
2022-12-31-$1.30
derived: net income ÷ weighted average shares · filed 2024-03-15
-$2.45
derived: net income ÷ weighted average shares · filed 2024-03-15
-$3.29
derived: net income ÷ weighted average shares · filed 2024-03-15
-$4.81
10-K · filed 2024-03-15
2022-09-30-$1.15
10-Q · filed 2023-11-13
-$0.08
10-Q · filed 2022-11-10
-$1.98
derived: net income ÷ weighted average shares · filed 2023-11-13
-$3.50
10-Q · filed 2023-11-13
-$0.23
10-Q · filed 2022-11-10
$0.60
derived: net income ÷ weighted average shares · filed 2023-11-13
2022-06-30-$0.83
10-Q · filed 2023-08-21
-$0.06
10-Q · filed 2022-08-12
-$2.35
10-Q · filed 2023-08-21
-$0.16
10-Q · filed 2022-08-12
$0.34
derived: net income ÷ weighted average shares · filed 2023-08-21
$0.99
derived: net income ÷ weighted average shares · filed 2023-08-21
2022-03-31-$1.52
10-Q · filed 2023-05-15
-$0.10
10-Q · filed 2022-05-13
$0.17
derived: net income ÷ weighted average shares · filed 2023-05-15
$0.60
derived: net income ÷ weighted average shares · filed 2023-05-15
$2.50
derived: net income ÷ weighted average shares · filed 2023-05-15
2021-12-31$0.04
derived: net income ÷ weighted average shares · filed 2023-03-31
$0.25
derived: net income ÷ weighted average shares · filed 2023-03-31
$1.17
derived: net income ÷ weighted average shares · filed 2023-03-31
-$4.69
10-K · filed 2023-03-31
-$0.31
10-K · filed 2022-03-29
2021-09-30-$0.09
10-Q · filed 2022-11-10
-$0.14
derived: net income ÷ weighted average shares · filed 2022-11-10
-$0.20
10-Q · filed 2022-11-10
2021-06-30-$0.05
10-Q · filed 2022-08-12
-$0.11
10-Q · filed 2022-08-12
2021-03-31-$0.06
10-Q · filed 2022-05-13
2020-12-31-$0.64
10-K · filed 2022-03-29
2018-09-30-$0.11
10-Q · filed 2018-11-09
-$0.50
10-Q · filed 2018-11-09
2018-06-30-$0.18
10-Q · filed 2018-08-08
-$0.45
10-Q · filed 2018-08-08
2018-03-31-$0.27
10-Q · filed 2018-05-11
2017-12-31-$0.28
derived: net income ÷ weighted average shares · filed 2018-03-15
-$0.46
derived: net income ÷ weighted average shares · filed 2018-11-09
-$0.85
derived: net income ÷ weighted average shares · filed 2018-11-09
-$1.16
10-K · filed 2018-03-15
2017-09-30-$0.17
10-Q · filed 2018-11-09
-$0.58
derived: net income ÷ weighted average shares · filed 2018-11-09
-$0.89
10-Q · filed 2018-11-09
-$1.02
derived: net income ÷ weighted average shares · filed 2018-11-09
2017-06-30-$0.41
10-Q · filed 2018-08-08
-$0.73
10-Q · filed 2018-08-08
-$0.86
derived: net income ÷ weighted average shares · filed 2018-08-08
-$1.29
derived: net income ÷ weighted average shares · filed 2018-08-08
2017-03-31-$0.32
10-Q · filed 2018-05-11
-$0.43
derived: net income ÷ weighted average shares · filed 2018-05-11
-$0.86
derived: net income ÷ weighted average shares · filed 2018-05-11
-$0.94
derived: net income ÷ weighted average shares · filed 2018-05-11
2016-12-31-$0.08
derived: net income ÷ weighted average shares · filed 2018-03-15
-$0.53
derived: net income ÷ weighted average shares · filed 2018-03-15
-$0.58
derived: net income ÷ weighted average shares · filed 2018-03-15
-$0.93
10-K · filed 2018-03-15
2016-09-30-$0.49
10-Q · filed 2017-11-06
-$0.53
derived: net income ÷ weighted average shares · filed 2017-11-06
-$0.90
10-Q · filed 2017-11-06
-$1.59
derived: net income ÷ weighted average shares · filed 2017-11-06
2016-06-30-$0.03
10-Q · filed 2017-08-11
$0.00
10-Q · filed 2016-08-11
-$0.39
10-Q · filed 2017-08-11
-$0.04
10-Q · filed 2016-08-11
-$1.09
derived: net income ÷ weighted average shares · filed 2017-08-11
-$0.18
derived: net income ÷ weighted average shares · filed 2017-08-11
2016-03-31-$0.37
10-Q · filed 2017-05-11
-$0.04
10-Q · filed 2016-05-12
-$1.09
derived: net income ÷ weighted average shares · filed 2017-05-11
-$0.15
derived: net income ÷ weighted average shares · filed 2017-05-11
-$0.51
derived: net income ÷ weighted average shares · filed 2017-05-11
2015-12-31-$0.74
derived: net income ÷ weighted average shares · filed 2017-03-27
$0.26
derived: net income ÷ weighted average shares · filed 2017-03-27
-$0.31
derived: net income ÷ weighted average shares · filed 2017-03-27
-$3.00
10-K · filed 2017-03-27
-$0.30
10-K · filed 2016-03-24
2015-09-30$1.05
10-Q · filed 2016-11-10
$0.10
10-Q · filed 2015-11-12
-$0.08
derived: net income ÷ weighted average shares · filed 2016-11-10
-$2.26
10-Q · filed 2016-11-10
-$0.23
10-Q · filed 2015-11-12
-$0.21
derived: net income ÷ weighted average shares · filed 2016-11-10
2015-06-30-$0.15
10-Q · filed 2016-08-11
-$0.34
10-Q · filed 2016-08-11
-$0.27
derived: net income ÷ weighted average shares · filed 2016-08-11
-$0.47
derived: net income ÷ weighted average shares · filed 2016-08-11
2015-03-31-$0.19
10-Q · filed 2016-05-12
-$0.11
derived: net income ÷ weighted average shares · filed 2016-05-12
-$0.31
derived: net income ÷ weighted average shares · filed 2016-05-12
2014-12-31$0.09
derived: net income ÷ weighted average shares · filed 2016-03-24
-$0.11
derived: net income ÷ weighted average shares · filed 2016-03-24
-$0.32
10-K · filed 2016-03-24
2014-09-30-$0.21
10-Q · filed 2015-11-12
-$0.43
10-Q · filed 2015-11-12
2013-12-31-$0.65
10-K · filed 2015-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Imunon, Inc. (IMNN)United States$0.008B-0.56
EXICURE, INC. (XCUR)United States$0.008B-1.54
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97